C7 Sugar GMBH
USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, C7 ranks #45,413 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.
- #45,413
- of 49,997 US assignees by volume
- 11th percentile
- by Innovation Score (22.9/100)
- 13.4
- avg claims per patent
- -33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R45413 · Foreign Corporation #45,413 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #45,413/49,997
- PHOTO-FINISH C2N Diagnostics
- CPC-NARROW A61P · 6 areas
- INNOV-THIN 22.9/100
- CLAIMS-RICH 13.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: C2N Diagnostics (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How C7’s 22.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around C7
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- C7 Sugar · this assignee 23
C7 Sugar · this assignee
23 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows C7's Innovation Score is 22.9/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for C7?
Each dot is one of C7’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). C7’s own 13.4 claims/patent is at or below the 13.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where C7's grants concentrate
C7 Sugar GMBH is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2018. By volume, C7 sits between C2N Diagnostics and Calik Denim Tekstil SAN. VE TIC. A.S..
Who files at C7's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- C2N Diagnostics
C2N Diagnostics
5 patents
- C3 Jian
C3 Jian, LLC
5 patents
- C360
C360 Technologies, Inc.
5 patents
- C4 Carbides
C4 Carbides Limited
5 patents
- Ca-digital
Ca-digital GMBH
5 patents
- Cable Detection
Cable Detection Limited
5 patents
- Caddi
CADDi, Inc.
5 patents
- Calik Denim Tekst…
Calik Denim Tekstil SAN. VE TIC. A.S.
5 patents
- C7 Sugar ◀
C7 Sugar GMBH
5 patents
What this shows C7 holds 5 patents at rank #45,423, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near C7
By rank, the assignees closest to #45,423 in granted patent volume.
- C2N Diagnostics #45,419 · 5 patents
- C3 Jian, LLC #45,420 · 5 patents
- C360 Technologies, Inc. #45,421 · 5 patents
- C4 Carbides Limited #45,422 · 5 patents
- Ca-digital GMBH #45,424 · 5 patents
- Cable Detection Limited #45,425 · 5 patents
- CADDi, Inc. #45,426 · 5 patents
- Calik Denim Tekstil SAN. VE TIC. A.S. #45,427 · 5 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in C7's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
C7's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
23 11th percentile higher than 11% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 40.0% |
| 2018 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
Which technologies does C7 Sugar GMBH patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
C7 Sugar GMBH's patent record in context - here's where to go next.
- C7 Sugar GMBH's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #45,413 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare C7 Sugar GMBH against C2N Diagnostics, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 22.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.